Written question asked by James Clappison (Conservative) on Wednesday, 17 July 2002, in the House of Commons. It was due for an answer on Wednesday, 24 July 2002. It was answered by David Lammy (Labour) on Wednesday, 24 July 2002 on behalf of the Department of Health.

Dept of Health

Question: To ask the Secretary of State for Health, what proportion of drugs used in (a) the hospital service and (b) the community through the NHS are the subject of parallel importation from other European member states; what assessment he has made of the effect on the NHS of national quotas imposed by multinational drug companies to impede such activity; and if he will make a statement; what representations he has made to the European Commission in respect of the decision by Eli Lilly to impose a quota system in the supply of the drug Zyprexa in other European Union member states; what assessment he has made of the impact on the price of the drug Zyprexa to the NHS of the restriction of imports of the drug from other European member countries. - Includes figures but full information not available. (Holding answer 22 July 2002).

Secondary information

Type: Written question
Reference: 389 c1405-6W;389 c1403-4W; 71729;71730;71731
Session: 2001-02
Subjects: Competition law EU countries Drugs EU internal trade Imports NHS Prescription drugs Prices Quotas Zyprexa
Contains statistics: Yes
Link: View this Written question on www.publications.parliament.uk